BIOMAT Database Logo BIOMAT Database Logo

Oral slow-release nifedipine in the rapid treatment of severe hypertension in Nigerians. 1994

A Arije, and A B Omotoso, and R T Erasmus
Department of Medicine and Chemical Pathology, University of Ilorin, Nigeria.

The effect of the oral slow-release formulation of Nifedipine in rapidly lowering blood pressure was studied in 20 severely hypertensive Nigerians (8 males, 12 females). A significant fall (p < 0.05) in mean systolic, diatolic, and mean arterial pressure was obtained 30 minutes after administration of Nifedipine. The fall in all three parameters of blood pressure remained sustained and significant (p < 0.05) 6 hours after a single dose administration. Side effects were minimal and limited to headaches in 20% of patients and palpitations in 10%. All patients showed a sustained control of blood pressure over a three month follow up period on slow release Nifedipine. Addition of methyldopa resulted in improved blood pressure control in one patient with chronic renal failure. It was concluded that oral slow release Nifedipine is a drug of choice in the rapid and sustained control of blood pressure in severely hypertensive patients especially in a setting where critical intensive monitoring facilities are limited.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D009549 Nigeria A republic in western Africa, south of NIGER between BENIN and CAMEROON. Its capital is Abuja. Federal Republic of Nigeria
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Arije, and A B Omotoso, and R T Erasmus
[Treatment of arterial hypertension in chronic renal insufficiency with slow-release nifedipine].
January 1982, Minerva nefrologica,
A Arije, and A B Omotoso, and R T Erasmus
Oral nifedipine for the treatment of patients with severe hypertension.
October 1985, The American journal of medicine,
A Arije, and A B Omotoso, and R T Erasmus
Nifedipine for rapid control of severe hypertension.
December 1982, The New Zealand medical journal,
A Arije, and A B Omotoso, and R T Erasmus
Slow release nifedipine in the treatment of Raynaud's phenomenon.
January 1987, International angiology : a journal of the International Union of Angiology,
A Arije, and A B Omotoso, and R T Erasmus
Slow release nifedipine and atenolol as initial treatment in blacks with malignant hypertension.
April 1986, British journal of clinical pharmacology,
A Arije, and A B Omotoso, and R T Erasmus
Slow-release nifedipine associated with muzolimine in the treatment of mild to moderate essential hypertension.
January 1986, American journal of nephrology,
A Arije, and A B Omotoso, and R T Erasmus
Verapamil versus nifedipine in slow-release preparations for the treatment of mild to moderate hypertension.
August 1990, Journal of human hypertension,
A Arije, and A B Omotoso, and R T Erasmus
Long-term therapy with slow-release nifedipine in essential hypertension.
August 1990, Cardiovascular drugs and therapy,
A Arije, and A B Omotoso, and R T Erasmus
Slow-release nifedipine for treatment of arterial hypertension in patients with chronic renal failure.
January 1984, Contributions to nephrology,
A Arije, and A B Omotoso, and R T Erasmus
Oral enalapril-hydrochlorothiazide-methyldopa as first line treatment for severe hypertension in Nigerians.
January 2004, Tropical doctor,
Copied contents to your clipboard!